Last week, President Bush branded current vaccine production methods "antiquated" and asked Congress for a $2.8 billion "crash program" to help the industry develop simpler and more flexible "cell-culture" technologies that can better keep up with new flu strains. The question is whether they're willing to abandon the tried-and-true - or do it soon enough to head off the next potential public health disaster.
Changing vaccine systems no easy shot - baltimoresun.com
BioBOOM Op/Ed: Windfall...look for money to flow into large scale processing.
- ► 2013 (23)
- ► 2008 (24)
- ► 2007 (65)
- ► 2006 (77)
- Glaxo & Institut Pasteur hope to adapt measles sho...
- Merck to Cut Jobs, Close or Sell 5 Plants
- C.D.C. Proposes New Rules in Effort to Prevent Dis...
- Harvard affiliated hospitals to share large detail...
- Doctors Objecting to Planned Cut in Medicare Fees
- Pope Addresses Genome Conference
- Mixed Results for Lipitor Vs. Zocor
- Genetic Find Stirs Debate on Race-Based Medicine
- Appetite-Suppressing Hormone Discovered
- Biotech groups push for small-business rule change...
- Australian company to launch bird flu tests for H5...
- Changing vaccine systems no easy shot - baltimores...
- Commission recommends patient ID standard
- ▼ November (13)